Literature DB >> 23343164

Development of adenovirus capsid proteins for targeted therapeutic delivery.

Lali K Medina-Kauwe1.   

Abstract

The outer shell of the adenovirus capsid comprises three major types of protein (hexon, penton base and fiber) that perform the majority of functions facilitating the early stages of adenovirus infection. These stages include initial cell-surface binding followed by receptor-mediated endocytosis, endosomal penetration and cytosolic entry, and intracellular trafficking toward the nucleus. Numerous studies have shown that the penton base contributes to several of these steps and have supported the development of this protein into a delivery agent for therapeutic molecules. Studies revealing that the fiber and hexon bear unexpected properties of cell entry and/or nuclear homing have supported the development of these capsid proteins, as well into potential delivery vehicles. This review summarizes the findings to date of the protein-cell activities of these capsid proteins in the absence of the whole virus and their potential for therapeutic application with regard to the delivery of foreign molecules.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23343164      PMCID: PMC3645976          DOI: 10.4155/tde.12.155

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  77 in total

1.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin.

Authors:  C Y Chiu; P Mathias; G R Nemerow; P L Stewart
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Cellular uptake and nuclear delivery of recombinant adenovirus penton base.

Authors:  S S Hong; B Gay; L Karayan; M C Dabauvalle; P Boulanger
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

4.  Adenovirus protein VI mediates membrane disruption following capsid disassembly.

Authors:  Christopher M Wiethoff; Harald Wodrich; Larry Gerace; Glen R Nemerow
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  The Ad5 fiber mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway.

Authors:  A Rentsendorj; H Agadjanian; X Chen; M Cirivello; M Macveigh; L Kedes; S Hamm-Alvarez; L K Medina-Kauwe
Journal:  Gene Ther       Date:  2005-02       Impact factor: 5.250

6.  Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptors.

Authors:  A Garcel; E Gout; J Timmins; J Chroboczek; P Fender
Journal:  J Gene Med       Date:  2006-04       Impact factor: 4.565

7.  Specific delivery of corroles to cells via noncovalent conjugates with viral proteins.

Authors:  Hasmik Agadjanian; Jeremy J Weaver; Atif Mahammed; Altan Rentsendorj; Sam Bass; Jihee Kim; Ivan J Dmochowski; Ruth Margalit; Harry B Gray; Zeev Gross; Lali K Medina-Kauwe
Journal:  Pharm Res       Date:  2006-01-19       Impact factor: 4.200

8.  Structure of the dodecahedral penton particle from human adenovirus type 3.

Authors:  P Fuschiotti; G Schoehn; P Fender; C M S Fabry; E A Hewat; J Chroboczek; R W H Ruigrok; J F Conway
Journal:  J Mol Biol       Date:  2005-12-09       Impact factor: 5.469

9.  The structure of the human adenovirus 2 penton.

Authors:  Chloe Zubieta; Guy Schoehn; Jadwiga Chroboczek; Stephen Cusack
Journal:  Mol Cell       Date:  2005-01-07       Impact factor: 17.970

10.  Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer.

Authors:  A Rentsendorj; J Xie; M MacVeigh; H Agadjanian; S Bass; D-H Kim; J Rossi; S F Hamm-Alvarez; L K Medina-Kauwe
Journal:  Gene Ther       Date:  2006-05       Impact factor: 5.250

View more
  6 in total

Review 1.  Genetic-Driven Druggable Target Identification and Validation.

Authors:  Matteo Floris; Stefania Olla; David Schlessinger; Francesco Cucca
Journal:  Trends Genet       Date:  2018-05-23       Impact factor: 11.639

Review 2.  Oligonucleotide therapeutics in neurodegenerative diseases.

Authors:  Daniel R Scoles; Stefan M Pulst
Journal:  RNA Biol       Date:  2018-06-01       Impact factor: 4.652

3.  IRAM: virus capsid database and analysis resource.

Authors:  Iman Almansour; Mazen Alhagri; Rahaf Alfares; Manal Alshehri; Razan Bakhashwain; Ahmed Maarouf
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

4.  A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity.

Authors:  Jessica D Sims; Jae Youn Hwang; Shawn Wagner; Felix Alonso-Valenteen; Chris Hanson; Jan Michael Taguiam; Richard Polo; Ira Harutyunyan; Gevorg Karapetyan; Karn Sorasaenee; Ahmed Ibrahim; Eduardo Marban; Rex Moats; Harry B Gray; Zeev Gross; Lali K Medina-Kauwe
Journal:  J Control Release       Date:  2015-08-31       Impact factor: 9.776

5.  HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo.

Authors:  Felix Alonso-Valenteen; Sayuri Pacheco; Dustin Srinivas; Altan Rentsendorj; David Chu; Jay Lubow; Jessica Sims; Tianxin Miao; Simoun Mikhael; Jae Youn Hwang; Ravinder Abrol; Lali K Medina Kauwe
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

6.  Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors.

Authors:  Jingyi Yan; Jianing Dong; Jiaxin Wu; Rui Zhu; Zhen Wang; Baoming Wang; Lizheng Wang; Zixuan Wang; Haihong Zhang; Hui Wu; Bin Yu; Wei Kong; Xianghui Yu
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.